Biopharma News

Aug 24, 2017
By BioPharm International Editors
FDA grants priority review for emicizumab, an investigational bispecific monoclonal antibody, for treating hemophilia A with factor VIII inhibitors.
Aug 21, 2017
By BioPharm International Editors
Shire announced that CFO Jeff Poulton will be leaving the company at the end of the year. Additionally, Joanne Cordeiro has been appointed as CHRO.
Aug 21, 2017
By BioPharm International Editors
Shire announced that CFO Jeff Poulton will be leaving the company at the end of the year. Additionally, Joanne Cordeiro has been appointed as CHRO.
Aug 21, 2017
By BioPharm International Editors
The first program of this collaboration will focus on the development of a candidate for severe acute pancreatitis.
Aug 18, 2017
By BioPharm International Editors
The withdrawal has been attributed to issues at the biotech company’s manufacturing facility.
Aug 18, 2017
By BioPharm International Editors
FDA approves new molecular entity developed by Pfizer for treating a rare form of leukemia in adults.
Aug 16, 2017
By BioPharm International Editors
The US Patent and Trademark Office issued three new patents that extend protection for Alexion’s rare-disease drug, Soliris, for an additional 10 years.
Aug 16, 2017
By BioPharm International Editors
A research collaboration joins Aslan with an academic research institute for studying small-molecule cancer drug candidates.
Aug 16, 2017
By BioPharm International Editors
GlaxoSmithKline (GSK) opened a new vaccine manufacturing facility in Montrose, Scotland. The £44 million (US$57 million) facility will be used to manufacture aluminum salts, which are used for vaccine production.
Aug 15, 2017
By BioPharm International Editors
The antibody therapeutic failed to meet its primary endpoint in a Phase III study.
native1_300x100
lorem ipsum